Commodore Capital’s Immunovant IMVT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-750,990
| Closed | -$19.8M | – | 38 |
|
|
2024
Q2 | $19.8M | Hold |
750,990
| – | – | 1.35% | 22 |
|
|
2024
Q1 | $24.3M | Sell |
750,990
-249,010
| -25% | -$8.05M | 1.62% | 23 |
|
|
2023
Q4 | $42.1M | Hold |
1,000,000
| – | – | 3.68% | 8 |
|
|
2023
Q3 | $38.4M | Buy |
1,000,000
+100,000
| +11% | +$3.84M | 4.49% | 10 |
|
|
2023
Q2 | $17.1M | Sell |
900,000
-540,999
| -38% | -$10.3M | 1.92% | 17 |
|
|
2023
Q1 | $22.3M | Buy |
1,440,999
+290,494
| +25% | +$4.51M | 3.4% | 10 |
|
|
2022
Q4 | $20.4M | Buy |
+1,150,505
| New | +$20.4M | 3.08% | 11 |
|
|
2021
Q1 | – | Sell |
-83,782
| Closed | -$3.87M | – | 33 |
|
|
2020
Q4 | $3.87M | Buy |
+83,782
| New | +$3.87M | 2.1% | 23 |
|